Related Experiment Videos

[Fungal and parasitic infections during immunosupressive treatment (author's transl)]

Pathologie-Biologie
|February 1, 1976
PubMed

Insights

Deep visceral fungal infections are increasing in immunosuppressed patients, particularly transplant recipients. Early diagnosis and treatment with amphotericin B and 5-fluorocytosine show promising results against candidiasis, cryptococcosis, and aspergillosis.

Area of Science:

  • Mycology
  • Immunocompromised Host Infections
  • Antifungal Therapy

Context:

  • Deep visceral fungal infections are emerging complications in patients receiving immunosuppressive therapy, including corticosteroids and organ transplants.
  • The Mycology Unit of the Pasteur Institute utilizes advanced mycological and immunological diagnostic techniques.
  • A series of 106 cases of deep candidiasis and 8 cases of cryptococcosis were diagnosed and treated.

Purpose:

  • To report the experience of the Mycology Unit at the Pasteur Institute in diagnosing and managing deep visceral fungal infections.
  • To present mycological, immunological, and therapeutic data for patients treated with amphotericin B and 5-fluorocytosine.
  • To review the literature on fungal infections and other opportunistic parasitic infections in immunocompromised patients, especially renal transplant recipients.

Summary:

  • The study details 24 cases of deep visceral candidiasis with septicemia in patients on immunosuppressants, including transplant recipients, treated with amphotericin B and 5-fluorocytosine.
  • Eight cases of cryptococcosis, occurring post-corticotherapy, radiotherapy, or renal transplantation, showed favorable outcomes with the same treatments (6 cures out of 8).
  • Two cases of aspergillosis, one successfully treated early in a renal transplant patient, and another fatal case in a heart transplant patient, are also presented.

Impact:

  • Highlights the increasing incidence and severity of deep fungal infections in immunocompromised individuals.
  • Demonstrates the efficacy of amphotericin B and 5-fluorocytosine in treating various deep mycoses, including candidiasis, cryptococcosis, and aspergillosis.
  • Emphasizes the importance of rapid laboratory diagnosis and prompt therapeutic intervention for improved patient outcomes in opportunistic infections.

Related Concept Videos